TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Phase: PHASE2 | Sponsor: M.D. Anderson Cancer Center | Compound: Psilocybin
- Status
- recruiting
- Institution
- M.D. Anderson Cancer Center
- Start date
- 2024-04-16
- End date
- 2026-12-31
- Registry ID
- NCT06200155
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.